ISB News

Xconomy Seattle 2035

Attend Xconomy’s Seattle 2035 on Oct. 30 at ISB’s event space (401 Terry Ave. N., Room 106). This conference, co-hosted by Northeastern University, highlights the next 20 years and beyond to explore long-term prospects of the local high-tech economy and what we can do to keep Seattle a city of the future. ISB President Dr. Lee Hood and ISB SVP and Director Dr. Nitin Baliga are featured speakers. The event takes place from 10 a.m. – 3:45 p.m., with a reception to follow. Register here: www.seattle2035.com.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.